Phenotype-Genotype Correlations of 13 Rare CYP21A2 Mutations Detected in 46 Patients Affected with 21-Hydroxylase Deficiency and in One Carrier
The DOI matches its Crossref record; 48 of the 56 references it cites were found in a registry or an index.
Abstract
Context: Steroid 21-hydroxylase deficiency is the most common enzymatic defect causing congenital adrenal hyperplasia with genotype/phenotype relationships for common mutations. Novel mutations of the CYP21A2 gene must be well studied to propose right genetic counseling for patients. Objective: Thirteen CYP21 mutations have been studied. A detailed description of phenotype was performed for all mutations (p.I77T, p.L167P, p.I230T, p.R233K, p.G291S, p.G292D, p.E320K, p.R341P, p.R354H, p.R369W, p.R408C, p.G424S, and p.R426H). In vitro and in silico studies were performed only for those not previously described (p.L167P, p.I230T, p.R233K, p.G292D, p.E320K, and p.R369W). Results: Regarding phenotype, patients with 10 of these mutations had a classical form. A patient with isolated p.I230T presented with nonclassical form and a patient with the association p.I230T + p.V281L in cis presented with a more severe phenotype. The p.R233K mutation was detected in a carrier partner. A patient with p.R369W presented with an intermediate form. Functional studies showed that all mutations except p.I230T and p.R369W decreased enzyme activity more than p.P30L: severity of p.R369W was intermediate between p.P30L and p.V281L, and finally p.I230T was less severe than p.V281L. Mutation analysis in a three-dimensional model structure of the CYP21 protein explained the observed in vitro effects, severe mutations being implicated in important functional domains of the protein. Conclusion: According to phenotype and functional studies, 11 of the mutations described, except the isolated p.R369W and p.I230T, may be responsible for a severe phenotype underlying the necessity to manage children having them. The p.I230T is a nonclassical mutation, and for the p.R369W, we need more cases to precise its severity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several reports in European, Mediterranean, Middle Eastern, and Chinese populations confirmed a high frequency of the pathogenic IVS2-13A/C > G and found it to comprise 20 to 25% of the CYP21A2 mutant alleles and to translate to the most severe SW forms of the disease when inherited in homozygosity [1, 4, 27, 39–43].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [42]
In the citing paper
“Tardy et al. demonstrated that a series of rare missense substitutions variably impair 21-hydroxylase activity, ranging from near-null to residual levels compatible with nonclassical CAH, by disrupting heme coordination, active-site geometry, or overall protein stability (37).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [37]
In the citing paper
“A huge study of 3200 patients in France found the intron 2 mutation in 30%, deletions and large gene conversions in 25%, I172N in 17%, and Q318X in 7% of alleles causing classic CAH, and, in nonclassic CAH, V281L was found in 55%, intron 2 in 9%, large rearrangements in 8%, I172N in 4%, and Q318X in 3% (431).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [431]
Citations
Cites
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241 · cited 1×
“Interaction of each mutant with heme, P, and oxidoreduction partners, were in silico analyzed with the Deep View program (Swiss Institute of Bioinformatics, Lausanne, Switzerland) (27).”
MethodCongenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Gotoh, O. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48462-1 · Cited by 1,194 · cited 1×
“Isoleucine 77 is localized in helix B, near the substrate recognition site 1 (38).”
BackgroundCrystal Structure of Hemoprotein Domain of P450BM-3, a Prototype for Microsomal P450's
Ravichandran, K. G., Boddupalli, S. S., Hasermann, C. A., Peterson, J. A., & Deisenhofer, J. (1993) · Science · doi:10.1126/science.8342039 · Cited by 877
Structure and function of cytochromes P450: a comparative analysis of three crystal structures
Hasemann, C. A., Kurumbail, R. G., Boddupalli, S. S., Peterson, J. A., & Deisenhofer, J. (1995) · Structure · doi:10.1016/s0969-2126(01)00134-4 · Cited by 692 · cited 1×
“3C); it is important for structural elaboration of the cysteine pocket; lacking any side chain, it enables the sharp turn in combination with glycine 430 (37) (Fig.”
BackgroundThe Protein Data Bank and the challenge of structural genomics.
Berman, H. M., Bhat, T. N., Bourne, P. E., Feng, Z., Gilliland, G. L., Weissig, H., & Westbrook, J. (2000) · Nature Structural Biology · doi:10.1038/80734 · Cited by 627 · cited 1×
“Homology modeling The model used for our study was the human CYP21A2, previously generated (25) and available at Protein Data Bank with identification 2GEG (26).”
MethodSpeiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555 · cited 1×
“The 21-hydroxylase gene locus has been characterized in detail (4) and genotype-phenotype correlations have been widely studied in various ethnic and racial groups (5–9).”
BackgroundKrone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397
Pang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392 · cited 6×
“In most populations, classical CAH occurs in approximately one in 14,000 live births (3) and is constituted by the simple virilizing (SV) and the salt wasting (SW) forms.”
BackgroundInfluentialWedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Tusie-Luna, M. T., Traktman, P., & White, P. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45304-x · Cited by 254 · cited 2×
“515T A) with about 2% residual 21hydroxylase activity and responsible for SV (14), two mutations associated with the NC form, p.”
BackgroundMutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency
Amor, M., Parker, K. L., Globerman, H., New, M. I., & White, P. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1600 · Cited by 251 · cited 17×
“The new p.E320K (c.958 G A) was identified in male 42, bearing the p.I172N in trans.”
BackgroundInfluentialPang, S., Wallace, M. A., Hofman, L. F., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · PEDIATRICS · doi:10.1542/peds.81.6.866 · Cited by 191
Tusie-Luna, M.-T., Speiser, P. W., Dumic, M., New, M. I., & White, P. C. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-5-685 · Cited by 183
Clinical and Molecular Genetics of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Morel, Y., & Miller, W. L. (1991) · Advances in Human Genetics · doi:10.1007/978-1-4684-5958-6_1 · Cited by 158
Self-citationTHE MOLECULAR GENETICS OF 21-HYDROXYLASE DEFICIENCY
Miller, W. L., & Morel, Y. (1989) · Annual Review of Genetics · doi:10.1146/annurev.ge.23.120189.002103 · Cited by 127
Self-citationHelmberg, A., Tusie-Luna, M. T., Tabarelli, M., Kofler, R., & White, P. C. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.8.1406709 · Cited by 123 · cited 2×
“The third group includes mutations such as p.V281L (14) and p.P453S (16, 17) that produce enzymes retaining 20–70% of normal activity, depending on the experimental conditions and associated with NC.”
BackgroundCongenital Adrenal Hyperplasia
White, P. C., New, M. I., & Dupont, B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706183162506 · Cited by 123
Bachega, T. A. S. S., Billerbeck, A. E. C., Madureira, G., Marcondes, J. A. M., Longui, C. A., Leite, M. V., Arnhold, I. J. P., & Mendonca, B. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5350 · Cited by 108 · cited 1×
“871G A), previously described in three patients with the SW form (20, 30), was detected in five patients (cases 4–8).”
BackgroundPinto, G., Tardy, V., Trivin, C., Thalassinos, C., Lortat-Jacob, S., Nihoul-Fékété, C., Morel, Y., & Brauner, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021433 · Cited by 101
Self-citationEarly Onset of Puberty: Tracking Genetic and Environmental Factors
Parent, A.-S., Rasier, G., Gerard, A., Heger, S., Roth, C., Mastronardi, C., Jung, H., Ojeda, S. R., & Bourguignon, J.-P. (2005) · Hormone Research in Paediatrics · doi:10.1159/000087753 · Cited by 88
Robins, T., Carlsson, J., Sunnerhagen, M., Wedell, A., & Persson, B. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0172 · Cited by 87 · cited 1×
“Homology modeling The model used for our study was the human CYP21A2, previously generated (25) and available at Protein Data Bank with identification 2GEG (26).”
MethodBachega, T. A. S. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.12.4416 · Cited by 80
Scott, R. R., Gomes, L. G., Huang, N., Van Vliet, G., & Miller, W. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2345 · Cited by 79 · cited 1×
“enzymatic deficiency, as androgen receptor (32) or P45 oxidoreductase (33) mutations.”
BackgroundBaumgartner-Parzer, S. M., Schulze, E., Waldhäusl, W., Pauschenwein, S., Rondot, S., Nowotny, P., Meyer, K., Frisch, H., Waldhauser, F., & Vierhapper, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7898 · Cited by 74 · cited 3×
“R426H was described as responsible for the SV form (34) or an intermediate SW-SV form (22).”
BackgroundInfluentialWedell, A. (1998) · Acta Paediatrica · doi:10.1111/j.1651-2227.1998.tb00968.x · Cited by 73
Lajić, S., Levo, A., Nikoshkov, A., Lundberg, Y., Partanen, J., & Wedell, A. (1997) · Human Genetics · doi:10.1007/s004390050436 · Cited by 72
Soardi, F. C., Barbaro, M., Lau, I. F., Lemos-Marini, S. H. V., Baptista, M. T. M., Guerra-Junior, G., Wedell, A., Lajic, S., & de Mello, M. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2594 · Cited by 65 · cited 2×
“(23) confirmed the very low residual activity around 1%, probably not sufficient for preventing SW (Fig.”
BackgroundBillerbeck, A. E. C., Mendonca, B. B., Pinto, E. M., Madureira, G., Arnhold, I. J. P., & Bachega, T. A. S. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011939 · Cited by 65 · cited 1×
“1222 C T) identified in four patients (cases 12–15) was published in eight patients with SW (23, 31).”
BackgroundFriães, A., Rêgo, A. T., Aragüés, J. M., Moura, L. F., Mirante, A., Mascarenhas, M. R., Kay, T. T., Lopes, L. A., Rodrigues, J. C., Guerra, S., et al. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.11.015 · Cited by 63 · cited 2×
“1270 G A) was identified in six patients (cases 22–27), with phenotypic features similar to eight of the 11 previously described (35, 36).”
BackgroundResultSynergistic Effect of Partially Inactivating Mutations in Steroid 21-Hydroxylase Deficiency1
Nikoshkov, A., Lajic, S., Holst, M., Wedell, A., & Luthman, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3678 · Cited by 61 · cited 2×
“The third group includes mutations such as p.V281L (14) and p.P453S (16, 17) that produce enzymes retaining 20–70% of normal activity, depending on the experimental conditions and associated with NC.”
BackgroundNikoshkov, A., Lajic, S., Vlamis-Gardikas, A., Tranebjærg, L., Holst, M., Wedell, A., & Luthman, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6163 · Cited by 47 · cited 1×
“871G A), previously described in three patients with the SW form (20, 30), was detected in five patients (cases 4–8).”
BackgroundLepesheva, G. I., Podust, L. M., Bellamine, A., & Waterman, M. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102767200 · Cited by 45
Krone, N., Riepe, F. G., Grötzinger, J., Partsch, C.-J., & Sippell, W. G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0813 · Cited by 43
A 3D model of human P450c21: study of the putative effects of steroid 21-hydroxylase gene mutations
Mornet, E., & Gibrat, J.-F. (2000) · Human Genetics · doi:10.1007/s004390051046 · Cited by 41
Hsu, L.-C., Hsu, N.-C., Guzova, J. A., Guzov, V. M., Chang, S.-F., & Chung, B.-C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3306 · Cited by 41 · cited 1×
“I172N (13); residual 21hydroxylase activity is very low but sufficient to prevent from neonatal SW (14, 15).”
BackgroundA Novel Missense Mutation, GLY424SER, in Brazilian Patients with 21-Hydroxylase Deficiency1
Billerbeck, A. E. C., Bachega, T. A. S. S., Frazzatto, E. T., Nishi, M. Y., Goldberg, A. C., Marin, M. L. C., Madureira, G., Monte, O., Arnhold, I. J. P., & Mendonca, B. B. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5937 · Cited by 40 · cited 1×
“1270 G A) was identified in six patients (cases 22–27), with phenotypic features similar to eight of the 11 previously described (35, 36).”
ResultFunctional studies of two novel and two rare mutations in the 21-hydroxylase gene
Barbaro, M., Baldazzi, L., Balsamo, A., Lajić, S., Robins, T., Barp, L., Pirazzoli, P., CACCIARI, E., Cicognani, A., & Wedell, A. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0043-7 · Cited by 40
p.H62L, a Rare Mutation of the CYP21 Gene Identified in Two Forms of 21-Hydroxylase Deficiency
Menassa, R., Tardy, V., Despert, F., Bouvattier-Morel, C., Brossier, J. P., Cartigny, M., & Morel, Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2701 · Cited by 38 · cited 3×
“I172N: as we previously reported, not all the 270 females were virilized and among the 130 children with neonatal screening, eight were false-negative cases (12).”
MethodResultInfluentialSelf-citationForest, M. G. (2003) · Diagnostics of Endocrine Function in Children and Adolescents · doi:10.1159/000073560 · Cited by 36
Synergistic Effect of Partially Inactivating Mutations in Steroid 21-Hydroxylase Deficiency
Nikoshkov, A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.194 · Cited by 34
A Novel Missense Mutation, GLY424SER, in Brazilian Patients with 21-Hydroxylase Deficiency
Billerbeck, A. E. C. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2870 · Cited by 31
Nunez, B. S., Lobato, M. N., White, P. C., & Meseguer, A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1271 · Cited by 23 · cited 2×
“1061G A) identified in two related females (cases 10–11) was previously described in one SW patient (21).”
BackgroundGiwercman, Y. L. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2623 · Cited by 22 · cited 1×
“enzymatic deficiency, as androgen receptor (32) or P45 oxidoreductase (33) mutations.”
BackgroundTHE STRUCTURE OF MICROSOMAL CYTOCHROME P450 2C5: A STEROID AND DRUG METABOLIZING ENZYME
Johnson, E. F., Wester, M. R., & Stout, C. D. (2002) · Endocrine Research · doi:10.1081/erc-120016820 · Cited by 18 · cited 1×
“Helix G is involved in the two substrate access channels, which have been proposed to connect the surface of the protein to the active site (41) (Fig.”
BackgroundBush, I. E. (1959) · BMJ · doi:10.1136/bmj.2.5163.1405 · Cited by 2
Research works printed but not linked: 1
- Tardy, 2005, Detection of heterozygotes for 21-hydroxylase deficiency: validation of 21-deoxycortisol after ACTH test by sequencing of the entire CYP21 gene, Horm Res, 64, 41
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Human cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
“A study of 3200 French patients [124] found an intron-2 mutation in 30 per cent, deletions and large gene conversions in 25 per cent, Ile172Asn in 17 per cent and Gln318Xaa in 7 per cent of alleles causing classic CAH; in non-classic CAH, Val281Leu was found in 55 per cent, intron-2 mutations in 9 per cent, large rear…”
BackgroundNew, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365
“J Clin Endocrinol Metab 95(3):1288–1300.”
Carmina, E., Dewailly, D., Escobar-Morreale, H. F., Kelestimur, F., Moran, C., Oberfield, S., Witchel, S. F., & Azziz, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx014 · Cited by 201
Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 159
Metadata
- Authors
- Tardy, V., Menassa, R., Sulmont, V., Lienhardt-Roussie, A., Lecointre, C., Brauner, R., David, M., & Morel, Y.
- Affiliations
- Hôpital Femme Mère Enfant (FR)
- Centre Hospitalier Universitaire de Reims (FR)
- Centre Hospitalier Universitaire de Limoges (FR)
- Centre Hospitalier Universitaire de Rouen (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tardy, V.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-03-01
- Volume
- 95
- Issue
- 3
- Pages
- 1288-1300
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1980640153
- Cited by
- 73
- References
- 56
- Citations by year
- 2026: 2 · 2025: 3 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 1 · 2017: 3 · 2016: 7 · 2015: 5 · 2014: 4 · 2013: 7 · 2012: 4
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- CYP21A2 mutations, 21-hydroxylase deficiency, congenital adrenal hyperplasia, genotype-phenotype correlation, rare mutations, enzyme activity, endophenotypes, genetic counseling
- MeSH terms
- Adrenal Hyperplasia, Congenital, Animals, Cells, Cultured, Chlorocebus aethiops, Humans, Mutation, Phenotype, Protein Conformation, Steroid 21-Hydroxylase, Time Factors, Blotting, Western, 17-alpha-Hydroxyprogesterone, COS Cells, Genetic Predisposition to Disease, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.